bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.06.16.496466

Denoising Approach Affects Diagnostic Differences in Brain Connectivity across the Alzheimer's Disease Continuum

Abstract

Graph theory provides a promising technique to investigate Alzheimers disease (AD)-related alterations in brain connectivity. However, discrepancies exist in the reported disruptions that occur to network topology across the AD continuum, which may be attributed to differences in the denoising approach used in fMRI processing to remove the effect of non-neuronal sources from signal. The current study aimed to determine if diagnostic differences in graph metrics were dependent on nuisance regression strategy. Sixty cognitively normal (CN), 60 MCI, and 40 AD matched for age, sex, and motion, were selected from the ADNI database for analysis. Resting state images were preprocessed using AFNI (v21.2.04) and 16 nuisance regression approaches were employed, which included the unique combination of four nuisance regressors (derivatives of the realignment parameters, motion censoring [euclidean norm > 0.3mm], outlier censoring [outlier fraction > .10], bandpass filtering [0.01 - 0.1 Hz]). Graph metrics representing network segregation (clustering coefficient, local efficiency, modularity), network integration (largest connected component, path length, local efficiency), and small-worldness (clustering coefficient/path length) were calculated. The results showed a significant interaction between diagnosis and nuisance approach on path length, such that diagnostic differences were only evident when motion derivatives and censoring of both motion and outlier volumes were applied. Further, regardless of the denoising approach, AD patients exhibited less segregated networks and lower small-worldness than CN and MCI. Finally, independent of diagnosis, denoising strategy significantly affected the magnitude of nearly all metrics (except local efficiency), such that models including bandpass filtering had higher graph metrics than those without. These findings suggest the relative robustness of network segregation and small-worldness properties to denoising strategy. However, caution should be taken when interpreting path length findings across studies, as subtle variations in regression approach may account for discrepancies. Continued efforts should be taken towards harmonizing preprocessing pipelines across studies to aid replication efforts and build consensus towards understanding the mechanisms underlying pathological aging.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Blujus, J. K., Oh, H., ADNI,. 2022-06-21. Denoising Approach Affects Diagnostic Differences in Brain Connectivity across the Alzheimer's Disease Continuum. https://doi.org/10.1101/2022.06.16.496466

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗